Texas A&M Football

Defense in Review feat. Sean Porter: Texas A&M 41, Notre Dame 40

Notre scored 33 points (plus a touchdown on special teams) on Mike Elko's Texas A&M defense in Week 3, but the Aggies walked away with the win. Billy Liucci and Sean Porter break down the defensive showing from the Maroon & White in a 41-40 win at Notre Dame Stadium.
By Billy Liucci
September 17, 2025
4.8k Views
Discuss
Story Poster
Photo by MICHAEL CLUBB/SOUTH BEND TRIBUNE

1. The Aggie defense needs to get better. Period. Too many wide-open Irish receivers resulted in easy yards, several big plays and momentum-changing third-down conversions. That said, the unit made more good plays in four quarters against the Irish ground game than in two wins vs. inferior opposition in games one and two.

To watch this video, you must be a TexAgs Premium subscriber.
Get Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Mike Elko Sean Porter Defense in Review Haynes King Mike Denbrock Arch Manning DJ Lagway Garrett Nussmeier Taylen Green LaNorris Sellers Blake Shapen Jackson Arnold
Show All
Jeremiyah Love Jadarian Price Diego Pavia Beau Pribula Gunner Stockton Texas A&M at Notre Dame Amari Daniels Albert Regis DJ Hicks Tyreek Chappell Le'Veon Moss Tyler Onyedim Dalton Brooks Marcel Reed Daymion Sanford Dezz Ricks Mario Craver Marcus Ratcliffe Will Lee III Scooby Williams Cashius Howell Koli Faaiu Football Texas A&M Notre Dame Georgia Vanderbilt Tennessee Georgia Tech 2025
SPONSORED BY
Spec's
More Football
See All →
Setting the Scene: A&M returns from bye with top-25 bout at Mizzou
By Richard Zane
'Desperate' Aggies anticipate a playoff-like atmosphere at Faurot Field
By Olin Buchanan
Pick Six: The TexAgs crew picks six games against the spread
By TexAgs Live
The Final Countdown: Liucci & McKinney Bros. preview Aggies-Tigers
By David Nuño
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.